Back to search
FDAFDA · Food and drugs·Recall number D-0427-2019

Medline Remedy Essential Barrier Skin Protectant Ointment (petrolatum 59%) packaged in a) 2 oz tubes (NDC 53329-302-14) and b) 6 oz tubes (NDC 53329-302-41), Medline Industries Inc., Manufactured for Medline Industries Inc., Mundelien, IL 60060.

Published February 13, 2019 · Recall initiated: December 7, 2018

Summary

FDA records drug Class II recall D-0427-2019, published February 13, 2019 and initiated December 7, 2018. Recalling firm: US Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 7020 units; Lot: Lot # a) and b): 44G17, Exp. 05/2019. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

GMP Deviations: Out of specification results for Total Aerobic Microbial count in excipient purified water sample

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
US Pharmaceuticals Inc.
Distributor
Nationwide within the United States
Lot
Lot # a) and b): 44G17, Exp. 05/2019
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Medline Remedy Essential Barrier Skin Protectant Ointment (petrolatum 59%) packaged in a) 2 oz tubes (NDC 53329-302-14) and b) 6 oz tubes (NDC 53329-302-41), Medline Industries Inc., Manufactured for Medline Industries Inc., Mundelien, IL 60060. recalled?

Yes. FDA published recall D-0427-2019 on February 13, 2019. Reported hazard: GMP Deviations: Out of specification results for Total Aerobic Microbial count in excipient purified water sample

What should I do if I have this product?

Voluntary: Firm initiated · Letter